Covid-19 triggers research culture in Ayurveda, traditional medicines

Of 203 trials registered with the Clinical Trial Registry, 61.5% are from Ayush disciplines

GN Bureau | September 30, 2020


#Covid-19   #Novel Coronavirus   #healthcare   #Ayush ministry   #Ayurveda   #Yoga  
(Illustration: Ashish Asthana)
(Illustration: Ashish Asthana)

The Covid-19 pandemic has brought the spotlight on the health-promotive and disease-preventive solutions of Ayush (Ayurveda, Yoga, Unani, Siddha, Homeopathy) disciplines. What has not come into the limelight is the emerging nationwide trend in the Ayush disciplines, of taking up evidence-based studies.

A study made a thorough search of the Clinical Trial Registry of India for the registered trials of Covid-19 involving ayurveda intervention from March 1 to June 25, without language restrictions. The number of new trials registered in Ayurveda during this period was seen to be 58, the Ayush ministry said in a release on Wednesday.

News reports in August had revealed that out of the 203 trials registered in Clinical Trial Registry of India (CTRI), 61.5% were from Ayush disciplines. A recent study published in the ‘Journal of Research in Ayurvedic Sciences’ titled “Ayurveda Research Studies on Covid-19 Registered in CTRI: A critical appraisal” throws more light on this growing “research-culture” in Ayush disciplines.

Here is some additional insight into these CTRI registered trials involving Ayurveda and Covid-19. Approximately 70% of the total trials registered were sponsored by the government and various stakeholders of Ayurveda associated with the Ayush ministry. These trials will provide useful information to the researchers which will help them to strategize the next course of action and also help the general public for understanding the contribution of Ayurveda in Covid-19.

Once completed, the results of these promising studies will expectedly be published at the earliest so that it will be useful for the policymakers from the Ayush systems of medicines to strategize effective solutions to benefit public health initiatives. Further, in these challenging times, they will provide information for the global scientific community to know about the outcomes of Ayurveda clinical trials being conducted on Covid-19 in India. They will form potential source of information for further collaborative studies at the national and global levels.

Out of the 58 registered trials, 52 (89.66%) are interventional trials and 6 (10.34%) are observational trials. The majority of the trials included adult participants of both the gender as the target population. A total of 53 (91.38%) trials intend to recruit participants aged 18 years or more, and only 05 (8.62%) trials intended to recruit participants younger than 18 years.

The instant paper, which is authored by researchers of the Central Council for Research in Ayurvedic Sciences, provides detailed information about Ayurveda based Covid-19 clinical trials with respect to administrative information on trial registry number and sponsorship, descriptive information on study type and length of study and study design. Further, it tracks information related to the registration date and actual study start date and information related to recruitment, and all these have been collated, presented, and analysed based on the trails’ information registered between March 1 and June 25 in the CTRI.

With an increasing number of registered trials in this field, the body of knowledge in Ayush disciplines will increasingly reflect more contemporary information. This trend of evidence-based studies in the Ayush sector holds considerable promise for the public health activities in the country, as the studies may lead to cost-effective solutions that could be deployed on a nationwide scale.

Comments

 

Other News

Maharashtra FDA cracks down on `health supplements`; seizes stock worth Rs 1.39 cr

The Maharashtra Food and Drug Administration (FDA) has issued a comprehensive state wide compliance order tightening regulations governing health supplements, nutraceuticals, sports nutrition products and foods for special dietary and medical purposes. The order, issued by Commissioner of Food Safety, Tu

States face rising fiscal pressure as spending outpaces revenue

States across India are facing increasing fiscal pressures, with revenue expenditure growing faster than revenue receipts since 2022-23, largely driven by rising subsidies and transfers, according to the annual ‘State of State Finances 2026-27’ report released by PRS Legislative Research.

Global value chains and sustainability

When a country’s factories become part of global supply chains, making parts or products that feed into goods sold around the world, the economy usually looks stronger. Output rises, exports grow, and technology improves. But the research behind this article [Bhayana and Nag, 2026] asks a harder qu

Narrative sovereignty in the digital age

In today’s world, competition between countries is not limited to military strength or economic power. It also takes place through the stories countries tell about themselves and the way others describe them. Social media and digital platforms have made this competition faster and more visible. Whe

The hidden cost of voter-ID link with welfare

On October 30, panchayati raj minister Rajiv Ranjan Singh, better known as Lalan Singh, told a national workshop in Delhi that Aadhaar would no longer be the basis for government schemes. His argument seemed simple enough. Aadhaar centres are now in every locality, and anyone can get a card made for anyb

The silent epidemic in the Northeast

In Mizoram, more than nine in ten people can read. Anyone there can find out how HIV spreads and how to protect themselves. Yet Mizoram has the highest rates of HIV patients in the country. If education were enough, this would’ve been solved long ago, but it was not. The answer tells us something a

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter